antimicrobial resistance

News

Data sets up filing of new GSK antibiotic this year

GSK has said it will file its oral carbapenem antibiotic tebipenem HBr for approval before the end of this year as a treatment for complicated UTIs.

Market Access

Reuters Europe 2025: Using value propositions to improve acc...

In a Reuters Pharma Europe 2025 fireside chat, NICE Advice Director Brad Grove spoke with Novartis's Matic Meglic about novel pharma payment models.

R&D

Jennifer Schneider’s insights on immunotherapy at JP Morgan ...

Jonah Comstock caught up with Jennifer Schneider, CEO of Centauri Therapeutics, in San Francisco in January during the JP Morgan Healthcare Conference

News

FDA clears new antibiotic for superbug infections

AbbVie has won FDA approval for Emblaveo, a new antibiotic to treat pathogens that pose serious public health threats.

News

Dr Marc Gitzinger, chief executive of BioVersys

AMR biotech BioVersys plans to float on Swiss stock exchange

BioVersys has filed to list on the Swiss Stock Exchange, hoping to raise CHF80m for its novel antibacterial candidates.

R&D

Growing threat of AMR: UN calls for urgent global action

In response to the rise of AMR, world leaders recently convened at the United Nations General Assembly to forge a landmark commitment, setting ambitious targets and funding initiatives to c

Data sets up filing of new GSK antibiotic this year

Reuters Europe 2025: Using value propositions to improve acc...

Jennifer Schneider’s insights on immunotherapy at JP Morgan ...

FDA clears new antibiotic for superbug infections

AMR biotech BioVersys plans to float on Swiss stock exchange

Growing threat of AMR: UN calls for urgent global action

OpenBind unveils its first AI model for drug discovery

Discover a new era of healthcare panel engagement: Grounded ...

antimicrobial resistance

Editor's Picks